Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: Results of a large Australian study

Thrombosis and Haemostasis

Volumn 107, Issue 3, 2012, Pages 575-583

  Morel Kopp, Marie Christine ^a,b   Tan, Chee Wee ^a,b   Brighton, Timothy A ^c   McRae, Simon ^d   Baker, Ross ^e   Tran, Huyen ^f   Mollee, Peter ^g   Kershaw, Geoffrey ^h   Joseph, Joanne ⁱ   Ward, Christopher ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d Department of Haematology SA Pathology ^*  (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ ST VINCENT S HOSPITAL   (Australia)

Author keywords

4T's score; Heparin; Heparin induced thrombocytopenia; Serotonin release assay; Whole blood impedance aggregometry

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; WHOLE BLOOD IMPEDANCE AGGREGOMETRY;

ADULT; ANTIBODIES; AUSTRALIA; DIAGNOSTIC TECHNIQUES, RADIOISOTOPE; DIAGNOSTIC TESTS, ROUTINE; ELECTRIC IMPEDANCE; FEASIBILITY STUDIES; FEMALE; HEMATOLOGIC TESTS; HEPARIN; HUMANS; MALE; OBSERVER VARIATION; PLATELET AGGREGATION; PLATELET FACTOR 4; PLATELET FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SEROTONIN; THROMBOCYTOPENIA;

EID: 84857746149     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-09-0631     Document Type: Article

References (48)

1. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96.
2. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995; 73: 21-28.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7.
4. Davenport A. Heparin-induced thrombocytopenia during renal replacement therapy. Hemodial Int 2004; 8: 295-303.
5. Matsuo T, Wanaka K. Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis. Clin Appl Thromb Hemost 2008; 14: 459-464.
6. Morel-Kopp MC, Aboud M, Tan CW, et al. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. Thromb Res 2010; 125: e234-239.
7. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535-555.
8. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-765.
9. Worthington RE, Carroll RC, Boucheix C. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol 1990; 74: 216-222.
10. Morel MC, Lecompte T, Champeix P, et al. PL2-49, a monoclonal antibody against glycoprotein IIb which is a platelet activator. Br J Haematol 1989; 71: 57-63.
11. Warmerdam PA, van de Winkel JG, Gosselin EJ, et al. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med 1990; 172: 19-25.
12. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
13. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007; 82: 1037-1043.
14. Messmore HL, Fabbrini N, Bird ML, et al. Simple Scoring System for the Early Management of Heparin-Induced Thrombocytopenia. Clin Appl Thromb Hemost 2011; 17: 197-201.
15. Pouplard C, Gueret P, Fouassier M, et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007; 5: 1373-1379.
16. Bryant A, Low J, Austin S, et al. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Br J Haematol 2008; 143: 721-726.
17. Cuker A. Heparin-induced thrombocytopenia: present and future. J Thromb Thrombolysis 2011; 31: 353-366.
18. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program 2010; 2010: 135-143.
19. Price EA, Hayward CP, Moffat KA, et al. Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories. Thromb Haemost 2007; 98: 1357-1361.
20. Bidet A, Tardy Poncet B, Desprez D, et al. Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France. Thromb Res 2010; 125: e294-299.
21. Bakchoul T, Giptner A, Najaoui A, et al. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2009; 103: 145-150.
22. Schneiter S, Colucci G, Sulzer I, et al. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA. J Thromb Haemost 2009; 7: 1649-1655.
23. Greinacher A, Kohlmann T, Strobel U, et al. The temporal profile of the anti-PF4/heparin immune response. Blood 2009; 113: 4970-4976.
24. Pouplard C, Leroux D, Regina S, et al. Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Thromb Haemost 2010; 103: 145-150.
25. Morel-Kopp MC, Aboud M, Tan CW, et al. Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays. Int J Lab Hematol 2011; 33: 245-250.
26. Whitlatch NL, Kong DF, Metjian AD, et al. Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood 2010; 116: 1761-1766.
27. Bakchoul T, Giptner A, Bein G, et al. Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). Thromb Res 2011; 127: 345-348.
28. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395-401.
29. Chong BH, Grace CS, Rozenberg MC. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets. Br J Haematol 1981; 49: 531-540.
30. Greinacher A, Michels I, Kiefel V, et al. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991; 66: 734-736.
31. Lee DH, Warkentin TE, Denomme GA, et al. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 1996; 95: 724-731.
32. Mullier F, Bailly N, Cornet Y, et al. Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia. Thromb Haemost 2010; 103: 1277-1281.
33. Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparininduced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparininduced thrombocytopenia. Blood 1994; 84: 3691-3699.
34. Jy W, Mao WW, Horstman LL, et al. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost 1999; 82: 1255-1259.
35. Denys B, Stove V, Philippe J, et al. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia. Thromb Res 2008; 123: 137-145.
36. Khairy M, Lasne D, Brohard-Bohn B, et al. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates. Thromb Haemost 2001; 85: 1090-1096.
37. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 1997; 98: 648-656.
38. Tardy-Poncet B, Piot M, Chapelle C, et al. Thrombin generation and heparin-induced thrombocytopenia. J Thromb Haemost 2009; 7: 1474-1481.
39. Toth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96: 781-788.
40. Ockenhouse CF, Magowan C, Chulay JD. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest 1989; 84: 468-475.
41. Clark MR, Stuart SG, Kimberly RP, et al. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol 1991; 21: 1911-1916.
42. Tomiyama Y, Kunicki TJ, Zipf TF, et al. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood 1992; 80: 2261-2268.
43. Reilly AF, Norris CF, Surrey S, et al. Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism. Clin Diagn Lab Immunol 1994; 1: 640-644.
44. Eichler P, Budde U, Haas S, et al. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost 1999; 81: 625-629.
45. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol 2010; 85: 700-706.
46. Pauzner R, Greinacher A, Selleng K, et al. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009; 7: 1070-1074.
47. Warkentin TE. Antiphospholipid and anti-PF4 antibodies: an association affecting anti-PF4/heparin assay analysis. J Thromb Haemost 2009; 7: 1067-1069.
48. Regnault V, de Maistre E, Carteaux JP, et al. Platelet activation induced by human antibodies to interleukin-8. Blood 2003; 101: 1419-1421.